Irene Volonghi Selected Research

Irene Volonghi Research Topics

5	COVID-19 10/2023 - 01/2020
4	Leukocytosis (Pleocytosis) 10/2023 - 01/2020
4	Stroke (Strokes) 04/2014 - 03/2009
3	Encephalitis (Encephalitis, Rasmussen) 10/2023 - 01/2020
3	Ischemic Stroke 09/2012 - 06/2009
2	Migraine Disorders (Migraine) 01/2011 - 03/2009
1	Brain Diseases (Brain Disorder) 10/2023
1	Hematologic Diseases (Blood Diseases) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2018
1	Brain Ischemia (Cerebral Ischemia) 04/2014
1	Myocardial Infarction 04/2014
1	Migraine with Aura (Familial Hemiplegic Migraine) 04/2014
1	Hematoma 02/2014
1	Pulmonary Embolism 09/2012
1	Thrombocytopenia (Thrombopenia) 09/2012
1	Blood Vessel Dissection 12/2011

3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 11/2021 - 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	AutoantibodiesIBA 10/2023
1	Chimeric Antigen ReceptorsIBA 10/2022
1	Chitinase-3-Like Protein 1IBA 11/2021
1	InterleukinsIBA 11/2021
1	Glial Fibrillary Acidic ProteinIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SteroidsIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Thymidine PhosphorylaseIBA 10/2018
1	NucleosidesIBA 10/2018
1	Antiphospholipid AntibodiesIBA 04/2014
1	Antihypertensive Agents (Antihypertensives)IBA 04/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	AnticoagulantsIBA 02/2014
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2012
1	Heparin (Liquaemin)FDA LinkGeneric 09/2012
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2011
1	Transforming Growth Factor-beta Type II ReceptorIBA 12/2011
1	factor V LeidenIBA 01/2011
1	Prothrombin (Factor II)IBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2009
1	Coenzyme A (CoA)IBA 06/2009
1	LipidsIBA 06/2009
1	CholesterolIBA 06/2009
1	Tryptamines (Triptans)IBA 03/2009
1	Ergot AlkaloidsIBA 03/2009